Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience, Inc. (ANRO) is a Biotechnology company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $956M; returns 1 day -1.0%, 1 week +0.1%, 1 year +96.5%.

Alto Neuroscience, Inc. (NYSE: ANRO) is a clinical-stage biopharmaceutical company dedicated to developing precision medicines for neuropsychiatric disorders.

Groups ANRO belongs to

• Biotechnology
• Clinical Stage Biotech
• Neuroscience
• CNS Disorders
• Neurological Disorders
• Clinical Stage
• Precision Medicine
• Healthcare
• Mental Health Solutions
• Biopharmaceutical
• Personalized Medicine
• Drug Discovery
• AI in Healthcare

ANRO financial model: income statement, cash flow and balance sheet